Health-related quality of life in Egyptian patients with familial Mediterranean fever
Middle East Journal of Medical Genetics · 2022
DOI: 10.21608/mxe.2023.283882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Middle East Journal of Medical Genetics, 2022. Verfasst von Manal Thomas und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Familial Mediterranean fever (FMF) is an auto-inflammatory disease, characterized by frequent attacks of fever and polyserositis. The chronic disease course and its burden with the life-long medications have an effect on the outcomes of health-related quality of life (HRQoL) in patients with FMF.
Objectives
To evaluate the outcomes of HRQoL and related risk factors in a large cohort of Egyptian patients with FMF.Patients and Methods: A total of 118 patients and 100 controls were enrolled from the Clinical Genetics Department, National Research Center, Cairo, Egypt. The Arabic version of Pediatric Quality of Life (PedsQLTM) Inventory 4.0 Generic Core Scale was used to assess the HRQoL outcomes.
Results
The outcome scores of HRQoL were lower in patients with FMF in comparison with the controls in all domains (P
Zitieren
APA
Thomas, M., El-Bassyouni, H., El-Massieh, P. A., & Hamed, K. (2022). Health-related quality of life in Egyptian patients with familial Mediterranean fever. Middle East Journal of Medical Genetics. https://doi.org/10.21608/mxe.2023.283882
Vancouver
Thomas M, El-Bassyouni H, El-Massieh PA, Hamed K. Health-related quality of life in Egyptian patients with familial Mediterranean fever. Middle East Journal of Medical Genetics. 2022. doi:10.21608/mxe.2023.283882
BibTeX
@article{Thomas2022,
author = {Thomas, Manal and El-Bassyouni, Hala and El-Massieh, Phoebe Abd and Hamed, Khaled},
title = {Health-related quality of life in Egyptian patients with familial Mediterranean fever},
journal = {Middle East Journal of Medical Genetics},
year = {2022},
doi = {10.21608/mxe.2023.283882}
}
EUVIMED